• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺胆酸在胆汁淤积条件下通过 S1PR2/p38 MAPK/YAP 信号促进肝星状细胞激活。

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.

机构信息

School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, Jiangsu, China.

Jiangsu Center Pharmacodynamic Research and Evaluation, China Pharmaceutical University, Nanjing, China.

出版信息

Clin Mol Hepatol. 2023 Apr;29(2):465-481. doi: 10.3350/cmh.2022.0327. Epub 2023 Feb 20.

DOI:10.3350/cmh.2022.0327
PMID:36800698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10121313/
Abstract

BACKGROUND/AIMS: Disrupted bile acid regulation and accumulation in the liver can contribute to progressive liver damage and fibrosis. However, the effects of bile acids on the activation of hepatic stellate cells (HSCs) remain unclear. This study investigated the effects of bile acids on HSC activation during liver fibrosis, and examined the underlying mechanisms.

METHODS

The immortalized HSCs, LX-2 and JS-1cells were used for the in vitro study. in vitro, the adeno-associated viruses adeno-associated virus-sh-S1PR2 and JTE-013 were used to pharmacologically inhibit the activity of S1PR2 in a murine model of fibrosis induced by a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet. Histological and biochemical analyses were performed to study the involvement of S1PR2 in the regulation of fibrogenic factors as well as the activation properties of HSCs.

RESULTS

S1PR2 was the predominant S1PR expressed in HSCs and was upregulated during taurocholic acid (TCA) stimulation and in cholestatic liver fibrosis mice. TCA-induced HSC proliferation, migration and contraction and extracellular matrix protein secretion were inhibited by JTE-013 and a specific shRNA targeting S1PR2 in LX-2 and JS-1 cells. Meanwhile, treatment with JTE-013 or S1PR2 deficiency significantly attenuated liver histopathological injury, collagen accumulation, and the expression of fibrogenesis-associated genes in mice fed a DDC diet. Furthermore, TCAmediated activation of HSCs through S1PR2 was closely related to the yes-associated protein (YAP) signaling pathway via p38 mitogen-activated protein kinase (p38 MAPK).

CONCLUSION

TCA-induced activation of the S1PR2/p38 MAPK/YAP signaling pathways plays a vital role in regulating HSC activation, which might be therapeutically relevant for targeting cholestatic liver fibrosis.

摘要

背景/目的:胆汁酸在肝脏中的调节和积累紊乱可导致进行性肝损伤和纤维化。然而,胆汁酸对肝星状细胞(HSCs)激活的影响尚不清楚。本研究旨在探讨胆汁酸在肝纤维化过程中对 HSC 激活的影响,并研究其潜在机制。

方法

本研究使用永生化的 HSCs(LX-2 和 JS-1 细胞)进行体外研究。在体外,使用腺相关病毒 adeno-associated virus-sh-S1PR2 和 JTE-013 抑制纤维化诱导的 3,5-二乙氧羰基-1,4-二氢胶原(DDC)饮食模型中小鼠 S1PR2 的活性。进行组织学和生化分析以研究 S1PR2 在调节纤维生成因子以及 HSCs 激活特性中的作用。

结果

S1PR2 是 HSCs 中表达最丰富的 S1PR,在牛磺胆酸(TCA)刺激和胆汁淤积性肝纤维化小鼠中上调。TCA 诱导的 HSC 增殖、迁移和收缩以及细胞外基质蛋白分泌在 LX-2 和 JS-1 细胞中被 JTE-013 和靶向 S1PR2 的特异性 shRNA 抑制。同时,用 JTE-013 或 S1PR2 缺乏治疗显著减轻了 DDC 饮食喂养的小鼠的肝组织病理损伤、胶原积累和纤维化相关基因的表达。此外,TCA 通过 S1PR2 介导的 HSCs 激活与 p38 丝裂原活化蛋白激酶(p38 MAPK)相关的 yes 相关蛋白(YAP)信号通路密切相关。

结论

TCA 诱导的 S1PR2/p38 MAPK/YAP 信号通路的激活在调节 HSC 激活中起关键作用,这可能与靶向胆汁淤积性肝纤维化的治疗有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/2331c4f935f4/cmh-2022-0327f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/a7a545a6cecb/cmh-2022-0327f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/5cc2585f152f/cmh-2022-0327f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/074b13dcf7a3/cmh-2022-0327f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/c8167b1fc4dd/cmh-2022-0327f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/b47ffc69090b/cmh-2022-0327f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/1d8541d36e1b/cmh-2022-0327f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/cbf084d52872/cmh-2022-0327f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/2331c4f935f4/cmh-2022-0327f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/a7a545a6cecb/cmh-2022-0327f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/5cc2585f152f/cmh-2022-0327f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/074b13dcf7a3/cmh-2022-0327f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/c8167b1fc4dd/cmh-2022-0327f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/b47ffc69090b/cmh-2022-0327f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/1d8541d36e1b/cmh-2022-0327f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/cbf084d52872/cmh-2022-0327f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/10121313/2331c4f935f4/cmh-2022-0327f8.jpg

相似文献

1
Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.牛磺胆酸在胆汁淤积条件下通过 S1PR2/p38 MAPK/YAP 信号促进肝星状细胞激活。
Clin Mol Hepatol. 2023 Apr;29(2):465-481. doi: 10.3350/cmh.2022.0327. Epub 2023 Feb 20.
2
The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.1-磷酸鞘氨醇受体2在胆汁酸诱导的小鼠胆管细胞增殖及胆汁淤积性肝损伤中的作用
Hepatology. 2017 Jun;65(6):2005-2018. doi: 10.1002/hep.29076. Epub 2017 Apr 28.
3
Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.外源性 S1P 通过 S1P 受体 2 通过Src-RhoA-ROCK-YAP 通路诱导肝星状细胞中 CTGF 的表达。
Mol Biol Rep. 2024 Sep 2;51(1):950. doi: 10.1007/s11033-024-09868-w.
4
Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.激活转录因子 6α 和肌醇需求酶 1α 的协调信号转导调控小鼠肝星状细胞介导的肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2021 May 1;320(5):G864-G879. doi: 10.1152/ajpgi.00453.2020. Epub 2021 Mar 17.
5
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.刺猬-YAP 信号通路调控谷氨酰胺代谢以控制肝星状细胞的激活。
Gastroenterology. 2018 Apr;154(5):1465-1479.e13. doi: 10.1053/j.gastro.2017.12.022. Epub 2018 Jan 3.
6
CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the Hedgehog pathway.CK2 阻断通过 Hedgehog 信号通路抑制肝星状细胞激活来减轻肝纤维化。
Br J Pharmacol. 2023 Jan;180(1):44-61. doi: 10.1111/bph.15945. Epub 2022 Sep 29.
7
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.JCAD 缺乏可减弱肝星状细胞的活化和胆汁淤积性纤维化。
Clin Mol Hepatol. 2024 Apr;30(2):206-224. doi: 10.3350/cmh.2023.0506. Epub 2024 Jan 8.
8
Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells.氧化应激通过调节肝星状细胞中的 microRNA-144 和 SIN3A-p38 通路促进肝纤维化。
Int J Biol Sci. 2024 Apr 8;20(7):2422-2439. doi: 10.7150/ijbs.92749. eCollection 2024.
9
NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα/MAPK signaling pathway.NLRP3 炎性小体在胆汁淤积性肝损伤中的预激活和激活:涉及鞘氨醇 1-磷酸/S1P 受体 2/Gα/MAPK 信号通路。
J Mol Med (Berl). 2021 Feb;99(2):273-288. doi: 10.1007/s00109-020-02032-4. Epub 2021 Jan 2.
10
Liver sinusoidal endothelial S1pr2 regulates experimental liver fibrosis through YAP/TGF-β signaling pathway.肝窦内皮细胞 S1pr2 通过 YAP/TGF-β 信号通路调节实验性肝纤维化。
FASEB J. 2023 May;37(5):e22905. doi: 10.1096/fj.202201954R.

引用本文的文献

1
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis.肝星状细胞与肝脏微环境之间的动态串扰:肝脏纤维化调控中的多细胞相互作用
Front Cell Dev Biol. 2025 Jul 21;13:1635763. doi: 10.3389/fcell.2025.1635763. eCollection 2025.
2
Diagnostic performance of Liver FibraChek Dx, a blood-based test for the non-invasive detection of liver cirrhosis and cancer.Liver FibraChek Dx的诊断性能,一种用于非侵入性检测肝硬化和癌症的血液检测方法。
World J Hepatol. 2025 Jun 27;17(6):106481. doi: 10.4254/wjh.v17.i6.106481.
3
TEAD4-mediated upregulation of LPAR3 augments hepatic stellate cell activation in portal hypertension.

本文引用的文献

1
A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs.一个保守的 YAP/Notch/REST 网络控制着肺部的神经内分泌细胞命运。
Nat Commun. 2022 May 16;13(1):2690. doi: 10.1038/s41467-022-30416-2.
2
Structural basis of sodium-dependent bile salt uptake into the liver.钠离子依赖的胆汁盐摄取进入肝脏的结构基础。
Nature. 2022 Jun;606(7916):1015-1020. doi: 10.1038/s41586-022-04723-z. Epub 2022 May 11.
3
Cholestatic liver diseases of genetic etiology: Advances and controversies.遗传病因性胆汁淤积性肝病:进展与争议。
TEAD4介导的LPAR3上调增强门静脉高压症中肝星状细胞的激活。
Cell Biol Toxicol. 2025 Jul 1;41(1):110. doi: 10.1007/s10565-025-10063-1.
4
Roles of Bile Acid-Activated Receptors in Monocytes-Macrophages and Dendritic Cells.胆汁酸激活受体在单核细胞-巨噬细胞和树突状细胞中的作用
Cells. 2025 Jun 18;14(12):920. doi: 10.3390/cells14120920.
5
Biological Actions of Bile Acids via Cell Surface Receptors.胆汁酸通过细胞表面受体的生物学作用。
Int J Mol Sci. 2025 May 22;26(11):5004. doi: 10.3390/ijms26115004.
6
A preliminary study of serum metabolomic profiling in male patients with acute brucellosis.男性急性布鲁氏菌病患者血清代谢组学分析的初步研究。
Sci Rep. 2025 May 6;15(1):15771. doi: 10.1038/s41598-025-00661-8.
7
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review).胆汁酸在结直肠癌肝转移中的新作用:从分子机制到临床意义(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5730. Epub 2025 Feb 21.
8
Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.巨噬细胞上S1PR2的激活以及在小胆管消失综合征中的肝细胞S1PR2/RhoA/ROCK1/MLC2通路
PLoS One. 2025 Jan 24;20(1):e0317568. doi: 10.1371/journal.pone.0317568. eCollection 2025.
9
Silybin Meglumine Mitigates CCl-Induced Liver Fibrosis and Bile Acid Metabolism Alterations.水飞蓟宾葡甲胺减轻四氯化碳诱导的肝纤维化和胆汁酸代谢改变。
Metabolites. 2024 Oct 17;14(10):556. doi: 10.3390/metabo14100556.
10
Gut‑liver axis in liver disease: From basic science to clinical treatment (Review).肠道-肝脏轴在肝脏疾病中的作用:从基础科学到临床治疗(综述)。
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13375. Epub 2024 Oct 25.
Hepatology. 2022 Jun;75(6):1627-1646. doi: 10.1002/hep.32437. Epub 2022 Mar 17.
4
Insufficient evidence for NTCP activity in stellate cells.星状细胞中NTCP活性的证据不足。
Gut. 2021 Dec 15;71(10):2140-1. doi: 10.1136/gutjnl-2021-326452.
5
Sodium/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.牛磺胆酸钠共转运蛋白作为肝纤维化的靶向治疗药物。
Gut. 2022 Jul;71(7):1373-1385. doi: 10.1136/gutjnl-2020-323345. Epub 2021 Jul 15.
6
Sphingolipids in metabolic disease: The good, the bad, and the unknown.代谢性疾病中的神经鞘脂:好的、坏的和未知的。
Cell Metab. 2021 Jul 6;33(7):1293-1306. doi: 10.1016/j.cmet.2021.06.006.
7
A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.熊去氧胆酸通过抑制巨噬细胞中 NLRP3 炎性小体的激活治疗 NASH 的新机制。
Metabolism. 2021 Jul;120:154797. doi: 10.1016/j.metabol.2021.154797. Epub 2021 May 10.
8
Clinical effects of NTCP-inhibitor myrcludex B.Myrcludex B 对 NTCP 抑制剂的临床效果。
J Viral Hepat. 2021 Jun;28(6):852-858. doi: 10.1111/jvh.13490. Epub 2021 Feb 28.
9
Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis.奥贝胆酸可改善原发性胆汁性胆管炎患者的肝脏胆汁酸排泄。
J Hepatol. 2021 Jan;74(1):58-65. doi: 10.1016/j.jhep.2020.07.028. Epub 2020 Jul 25.
10
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎纤维化发展的机制。
Gastroenterology. 2020 May;158(7):1913-1928. doi: 10.1053/j.gastro.2019.11.311. Epub 2020 Feb 8.